A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
Condition(s):Ulcerative Colitis (UC)Last Updated:November 14, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Ulcerative Colitis (UC)Last Updated:November 14, 2023Not yet recruiting
Condition(s):Immune-related Adverse Event; Diarrhea; Advanced Melanoma; Advanced Rectal CarcinomaLast Updated:December 23, 2022Not yet recruiting
Condition(s):Lynch Syndrome; Colon Cancer; Colon NeoplasmLast Updated:March 28, 2022Recruiting
Condition(s):Ulcerative ColitisLast Updated:October 10, 2023Not yet recruiting
Condition(s):Ulcerative ColitisLast Updated:September 26, 2023Recruiting
Condition(s):Ulcerative ColitisLast Updated:March 28, 2024Not yet recruiting
Condition(s):Inflammatory Bowel DiseasesLast Updated:March 22, 2023Recruiting
Condition(s):Inflammatory Bowel DiseasesLast Updated:December 28, 2023Recruiting
Condition(s):Ulcerative ColitisLast Updated:January 30, 2024Recruiting
Condition(s):Inflammatory Bowel DiseasesLast Updated:January 30, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.